Signal transducer and activator of transcription 6 (STAT6) and attention-deficit hyperactivity disorder: A speculative hypothesis

Medical Hypotheses

Volumn 67, Issue 6, 2006, Pages 1342-1344

  Tsai, Shih Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; STAT6 PROTEIN;

ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; BRAIN DISEASE; CORPUS STRIATUM; DOPAMINE BLOOD LEVEL; IMMUNE RESPONSE; LOCOMOTION; MOUSE; NEUROIMAGING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WILD TYPE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; HUMANS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; STAT6 TRANSCRIPTION FACTOR;

ANIMALIA;

EID: 33748977815     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.05.019     Document Type: Article

References (25)

1. Spencer T.J., Biederman J., Wilens T.E., and Faraone S.V. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatr 63 Suppl. 12 (2002) 3-9
2. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
3. Pliszka S.R., McCracken J.T., and Maas J.W. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatr 35 (1996) 264-272
4. Kent L., Green E., Hawi Z., Kirley A., Dudbridge F., Lowe N., et al. Association of the paternally transmitted copy of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatr 10 (2005) 939-943
5. Lanktree M., Muglia P., Squassina A., Krinsky M., Jain U., Macciardi F., et al. A potential role for brain derived neurotrophic factor (BDNF) in adult adhd (abstracts for the XIIth world congress of psychiatric genetics). Am J Med Gent 130B (2004) 96-97
6. Xu X., Mill J., Zhou K., Brookes K., Chen C., and Asherson P. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder (abstracts for XIII world congress on psychiatric genetics). Am J Med Gent 138B (2005) 53
7. Tsai S.J. Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis. Med Hypotheses 60 (2003) 849-851
8. Wurster A.L., Tanaka T., and Grusby M.J. The biology of Stat4 and Stat6. Oncogene 19 (2000) 2577-2584
9. Takeda K., Kishimoto T., and Akira S. STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 75 (1997) 317-326
10. Foster P.S. STAT6: an intracellular target for the inhibition of allergic disease. Clin Exp Allergy 29 (1999) 12-16
11. De-Fraja C., Conti L., Magrassi L., Govoni S., and Cattaneo E. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res 54 (1998) 320-330
12. De-Fraja C., Conti L., Govoni S., Battaini F., and Cattaneo E. STAT signalling in the mature and aging brain. Int J Dev Neurosci 18 (2000) 439-446
13. Cattaneo E., Conti L., and De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 22 (1999) 365-369
14. Yukawa K., Iso H., Tanaka T., Tsubota Y., Owada-Makabe K., Bai T., et al. Down-regulation of dopamine transporter and abnormal behavior in STAT6-deficient mice. Int J Mol Med 15 (2005) 819-825
15. Yukawa K., Tanaka T., Owada-Makabe K., Tsubota Y., Bai T., Maeda M., et al. Reduced prepulse inhibition of startle in STAT6-deficient mice. Int J Mol Med 16 (2005) 673-675
16. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatr 57 (2005) 1239-1247
17. Spencer T., Biederman J., and Wilens T. Pharmacotherapy of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 9 (2000) 77-97
18. Jucaite A., Fernell E., Halldin C., Forssberg H., and Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatr 57 (2005) 229-238
19. Taylor E. Developmental neuropsychopathology of attention deficit and impulsiveness. Dev Psychopathol 11 (1999) 607-628
20. Holden R.J., and Pakula I.S. Immunological influences in attention-deficit disorder and schizophrenia; is there a link between these two conditions?. Med Hypotheses 45 (1995) 575-587
21. Mittleman B.B., Castellanos F.X., Jacobsen L.K., Rapoport J.L., Swedo S.E., and Shearer G.M. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 159 (1997) 2994-2999
22. Segman R.H., Meltzer A., Gross-Tsur V., Kosov A., Frisch A., Inbar E., et al. Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatr 7 (2002) 72-74
23. Zhang W.J., Thompson J.L., Chorney M.J., and Koltun W.A. Phenotyping of IL4-induced nuclear Stat6 activity in humans: quantitation after gel shift assay using immortalized cell lines. Oncol Rep 10 (2003) 1281-1288
24. Amoli M., Ollier W.E., and Hajeer A.H. A novel PCR-RFLP assay for the detection of a polymorphism in the 3′ of STAT6 gene. Genes Immun 1 (2000) 349-350
25. Tamura K., Arakawa H., Suzuki M., Kobayashi Y., Mochizuki H., Kato M., et al. Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases. Clin Exp Allergy 31 (2001) 1509-1514